CyGene Laboratories Investor Relations

The Company was created to develop new technologies to meet the growing international interest in DNA profiling and diagnostics.

Since that time, CyGene has accumulated a wealth of scientific knowledge, talent and advanced technologies that have resulted in several significant achievements. The Company's proprietary Haystack Processing™ platform and AGENDA® (Advanced Genomic Diagnostic Analyzer) - its automated genomic analysis robotics for high speed and volume processing - have enabled CyGene to develop advanced DNA profiling processes. Today we are an industry leader in personalized genetics and DNA Analysis. Our business model that protects consumer anonymity while at the same time delivering customized DNA profiles has created an emerging market that reaches the consumer directly with a quality, value driven product.

These groundbreaking technologies, and other discoveries made during their development, provide the foundation for the Company's future growth in a number of diverse areas. CyGene's existing technologies can be applied to human diagnostics, plant pathogen detection, animal husbandry, quality control, therapeutics and many other fields.

At CyGene, we're committed to fulfilling the promise of more than 50 years of progress in biotechnology - to improve the quality of our lives.